Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Hereditary gynaecological malignancies: advances in screening and treatment.

Folkins AK, Longacre TA.

Histopathology. 2013 Jan;62(1):2-30. doi: 10.1111/his.12028. Review.

PMID:
23240667
2.

Hereditary non-BRCA gynecological tumors.

Vellone VG, Paudice M, Varesco L.

Minerva Ginecol. 2016 Oct;68(5):579-86. Epub 2016 Mar 1. Review.

PMID:
26930387
3.

Genetic testing by cancer site: ovary.

Weissman SM, Weiss SM, Newlin AC.

Cancer J. 2012 Jul-Aug;18(4):320-7. doi: 10.1097/PPO.0b013e31826246c2. Review.

PMID:
22846732
4.

Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.

Lancaster JM, Powell CB, Kauff ND, Cass I, Chen LM, Lu KH, Mutch DG, Berchuck A, Karlan BY, Herzog TJ; Society of Gynecologic Oncologists Education Committee.

Gynecol Oncol. 2007 Nov;107(2):159-62.

PMID:
17950381
5.

Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome.

Gerritzen LH, Hoogerbrugge N, Oei AL, Nagengast FM, van Ham MA, Massuger LF, de Hullu JA.

Fam Cancer. 2009;8(4):391-7. doi: 10.1007/s10689-009-9252-x. Epub 2009 Jun 6.

6.
7.
8.

[Recommendations for the management of women with an increased genetic risk of gynaecological cancer].

Verheijen RH, Boonstra H, Menko FH, de Graaff J, Vasen HF, Kenter GG.

Ned Tijdschr Geneeskd. 2002 Dec 14;146(50):2414-8. Review. Dutch.

PMID:
12518519
9.

Ovarian cancer associated with inherited mutations in BRCA1 or BRCA2.

Swisher E.

Curr Womens Health Rep. 2003 Feb;3(1):27-32. Review.

PMID:
12521547
10.

Ovarian cancer at young age: the contribution of mismatch-repair defects in a population-based series of epithelial ovarian cancer before age 40.

Escobar PF, Orr JW Jr, Grendys EC, Roland PY.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):876-7. Epub 2007 Nov 6. No abstract available.

PMID:
17986247
11.

Hereditary ovarian cancer.

Prat J, Ribé A, Gallardo A.

Hum Pathol. 2005 Aug;36(8):861-70. Review.

PMID:
16112002
12.

Susceptibility to breast cancer: hereditary syndromes and low penetrance genes.

Nusbaum R, Vogel KJ, Ready K.

Breast Dis. 2006-2007;27:21-50. Review.

PMID:
17917139
13.

Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.

Manchanda R, Menon U, Michaelson-Cohen R, Beller U, Jacobs I.

Curr Opin Obstet Gynecol. 2009 Feb;21(1):31-8. doi: 10.1097/GCO.0b013e32831c844d. Review.

PMID:
19125001
14.

Genetic profiles distinguish different types of hereditary ovarian cancer.

Domanska K, Malander S, Staaf J, Karlsson A, Borg A, Jönsson G, Nilbert M.

Oncol Rep. 2010 Oct;24(4):885-95.

PMID:
20811668
15.

Screening and prevention of hereditary gynecologic cancers.

Kehoe SM, Kauff ND.

Semin Oncol. 2007 Oct;34(5):406-10. Review.

PMID:
17920895
16.

Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.

Shulman LP.

Obstet Gynecol Clin North Am. 2010 Mar;37(1):109-33, Table of Contents. doi: 10.1016/j.ogc.2010.03.003. Review.

PMID:
20494261
17.

[Hereditary predispositions to gynaecological cancers].

Coupier I, Pujol P.

Gynecol Obstet Fertil. 2005 Nov;33(11):851-6. Epub 2005 Oct 26. French.

PMID:
16256400
18.

Genetic testing by cancer site: uterus.

Daniels MS.

Cancer J. 2012 Jul-Aug;18(4):338-42. doi: 10.1097/PPO.0b013e3182610cc2. Review.

PMID:
22846735
19.

Clinical management of women with genomic BRCA1 and BRCA2 mutations.

Chang J, Elledge RM.

Breast Cancer Res Treat. 2001 Sep;69(2):101-13. Review.

PMID:
11759816
20.

Familial breast and ovarian cancers.

Arai M, Utsunomiya J, Miki Y.

Int J Clin Oncol. 2004 Aug;9(4):270-82. Review.

PMID:
15375703

Supplemental Content

Support Center